SCHEMBL3624919

SCHEMBL3624919

CC(C)(C)c1cc(O)c(CNCCC(=O)O)c(C(C)(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR5A2 O00482 1/20 0.39
NR5A1 Q13285 1/20 0.39
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
RXRA P19793 1/20 0.37
RXRB P28702 1/20 0.37
RXRG P48443 1/20 0.37
S1PR5 Q9H228 5/20 0.36
GSR P00390 2/20 0.36
NPSR1 Q6W5P4 1/20 0.35
S1PR4 O95977 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3625966 0.84 NR5A2 (0.36) NR5A2NR5A1GSR
SCHEMBL3622829 0.83 NR5A2 (0.38) NR5A2NR5A1
SCHEMBL3621214 0.82 GSR (0.54) NR5A2NR5A1GSR
SCHEMBL3619585 0.82 NR5A2 (0.42) NR5A2NR5A1GSR
SCHEMBL3617344 0.80 NR5A2 (0.49) NR5A2NR5A1HDAC3HDAC1HDAC2
SCHEMBL3618691 0.79 NR5A2 (0.38) NR5A2NR5A1HDAC4HDAC2HDAC8
SCHEMBL3621104 0.79 CYP2C19 (0.37) NR5A2NR5A1HDAC1GSR
SCHEMBL3621681 0.78 MPO (0.48) HDAC1PTGS2
SCHEMBL3624485 0.78 NR5A2 (0.44) NR5A2NR5A1HDAC3HDAC1HDAC2
SCHEMBL3619703 0.78 NR5A2 (0.44) NR5A2NR5A1HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7834062-B2 Aminoalkylphenols, methods of using and making the same MERCK SHARP & DOHME CORP. (US) 2010-11-16 US disclosed
US-20090298949-A1 AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME MERCK SHARP & DOHME LLC 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298949-A1 AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME NPEPPS, PHOSPHO1, LNPEP NR5A2 4732/4885NR5A1 4748/4885HDAC3 2630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.